Source: International Congress 2018 – Management of idiopathic interstitial pneumonias: established and new treatments
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. Lindell (Pittsburgh, United States of America), M. Nouraie (Pittsburgh, United States of America), S. Klein (Pittsburgh, United States of America), M. Klesen (Pittsburgh, United States of America), K. Gibson (Pittsburgh, United States of America), D. Kass (Pittsburgh, United States of America), M. Rosenzweig (Pittsburgh, United States of America). Lessons learned when recruiting for an early Idiopathic Pulmonary Fibrosis (IPF) palliative care intervention. 4781

Member's Comments

No comment yet.

Related content which might interest you: A supportive care decision aid tool for idiopathic pulmonary fibrosis Source: International Congress 2016 – IPF: from pathogenesis to treatment II Year: 2016 Factors influencing Idiopathic Pulmonary Fibrosis (IPF) anti-fibrotic decisions in a single UK centre; patient and physician perspectives Source: International Congress 2018 – Management of idiopathic interstitial pneumonias: established and new treatments Year: 2018 End-of-life care in in-patients dying from pulmonary fibrosis Source: International Congress 2016 – ILD: from the bench to the bedside Year: 2016 IPF Care, a support program for patients with idiopathic pulmonary fibrosis in the UK Source: International Congress 2015 – Latest insights into chronic care Year: 2015 Do physicians in primary health care recognize pulmonary fibrosis? Source: International Congress 2015 – IPF: clinical aspects Year: 2015 Integrating early palliative care for patients with idiopathic pulmonary fibrosis and their caregivers Source: Virtual Congress 2020 – Fear and anxiety, psychological wellbeing and prevention of psychological distress in chronic lung diseases Year: 2020 Pulmonary rehabilitation programme in sarcoidosis Source: Eur Respir J 2005; 26: Suppl. 49, 333s Year: 2005 Nintedanib for idiopathic pulmonary fibrosis (IPF): Data from the German compassionate use program (CUP) Source: International Congress 2016 – IPF: from pathogenesis to treatment II Year: 2016 Development of the interstitial lung disease multidiciplinary team meeting 2005-2013 Source: International Congress 2015 – Kaleidoscope of nursing research Year: 2015 The burden of Idiopathic Pulmonary Fibrosis (IPF): a multimodal study of prevalence, healthcare utilization and survival Source: Virtual Congress 2020 – Clinical aspects of idiopathic pulmonary fibrosis Year: 2020 Exercise training in idiopathic pulmonary fibrosis: is it of benefit? Source: Breathe 2016; 12: 130-138 Year: 2016 The value of a specialist nurse-lead interstitial lung disease clinic, patients’ views Source: International Congress 2015 – Kaleidoscope of nursing research Year: 2015 Pirfenidone in idiopathic pulmonary fibrosis (IPF): Early Spanish experience with the European Named patient program (NPP) Source: Annual Congress 2013 –Diffuse parenchymal lung disease II Year: 2013 Progression of idiopathic pulmonary fibrosis (IPF): Lessons from asymmetrical disease Source: Annual Congress 2010 - Clinical issues in idiopathic pulmonary fibrosis Year: 2010 Repeat pulmonary rehabilitation programmes: Are they beneficial in COPD? Source: International Congress 2014 – Best posters in pulmonary rehabilitation 1 Year: 2014 Pulmonary rehabilitation in IPF Source: International Congress 2018 – Interstitial lung disease: an interdisciplinary approach Year: 2018 Lung transplantation, pulmonary rehabilitation and palliative care in IPF Source: Annual Congress 2009 - Idiopathic pulmonary fibrosis: evidence based guidelines and recommendations for clinical management - Results of the joint ATS/ERS/JRS taskforce Year: 2009 Pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis: Comparison with COPD Source: Annual Congress 2013 –Exercise, physiotherapy techniques and assessment in different chronic conditions Year: 2013 The European IPF Registry: Addressing challenges and characteristics of patients with Idiopathic Pulmonary Fibrosis Source: International Congress 2018 – The world of idiopathic pulmonary fibrosis (IPF): global registries Year: 2018